{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10788416", "DateCompleted": {"Year": "2000", "Month": "06", "Day": "16"}, "DateRevised": {"Year": "2024", "Month": "01", "Day": "09"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0099-2240", "JournalIssue": {"Volume": "66", "Issue": "5", "PubDate": {"Year": "2000", "Month": "May"}}, "Title": "Applied and environmental microbiology", "ISOAbbreviation": "Appl Environ Microbiol"}, "ArticleTitle": "Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori.", "Pagination": {"StartPage": "2269", "EndPage": "2273", "MedlinePgn": "2269-73"}, "Abstract": {"AbstractText": ["Chronic Helicobacter pylori disease is reduced with Allium vegetable intake. This study was designed to assess the in vivo anti-H. pylori potential of a variety of garlic substances. The garlic materials all showed substantial but widely differing anti-H. pylori effects against all strains and isolates tested. The MICs (range, 8 to 32 microg/ml) and minimum bactericidal concentrations (MBCs) (range, 16 to 32 microg/ml) of undiluted garlic oil (GO) were smaller than those of garlic powder (GP) (MIC range, 250 to 500 microg/ml; MBC range, 250 to 500 microg/ml) but greater than the MIC of allicin (4. 0 microg/ml) (Table 2) present in GP. Allicin (MIC, 6 microg/ml; MBC, 6 microg/ml) was more potent than diallyl disulfide (MIC range, 100 to 200 microg/ml; MBC range, 100 to 200 microg/ml), its corresponding sulfide, but of a strength similar to that of diallyl tetrasulfide (MIC range, 3 to 6 microg/ml; MBC range, 3 to 6 microg/ml). Antimicrobial activity of the diallyl sulfides increased with the number of sulfur atoms. Time course viability studies and microscopy showed dose-dependent anti-H. pylori effects with undiluted GO, GP, allicin, and diallyl trisulfide after a lag phase of ca. 1 to 2 h. Substantial in vitro anti-H. pylori effects of pure GO and GP and their diallyl sulfur components exist, suggesting their potential for in vivo clinical use against H. pylori infections."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Health Sciences, University of Wolverhampton, Wolverhampton WV1 1DJ, United Kingdom."}], "Identifier": [], "LastName": "O'Gara", "ForeName": "E A", "Initials": "EA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hill", "ForeName": "D J", "Initials": "DJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Maslin", "ForeName": "D J", "Initials": "DJ"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Appl Environ Microbiol", "NlmUniqueID": "7605801", "ISSNLinking": "0099-2240"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Allyl Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Disulfides"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Oils"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfides"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfinic Acids"}, {"RegistryNumber": "3C39BY17Y6", "NameOfSubstance": "allicin"}, {"RegistryNumber": "5HI47O6OA7", "NameOfSubstance": "diallyl disulfide"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Allyl Compounds"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Disulfides"}, {"QualifierName": [], "DescriptorName": "Garlic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Helicobacter pylori"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Oils"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sulfides"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sulfinic Acids"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bardhan K D, Wurzer H, Marcelino M, Jahnsen J, Lotay N, Roberts P M. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers. Am J Gastroenterol. 1998;93:380\u2013385.", "ArticleIdList": ["9517644"]}, {"Citation": "Bayerdr\u00f6ffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet. 1995;345:1591\u20131594.", "ArticleIdList": ["7783535"]}, {"Citation": "Bell G D, Powell K U, Burridge S M, Bowden A N, Rameh B, Bolten G, Purser K, Harrison G, Brown C, Gant P W, Jones P H, Trowell J E. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med J Assoc Phys. 1993;86:743\u2013750.", "ArticleIdList": ["8265776"]}, {"Citation": "Buiatti E, Palli D, Decarli A, Amadori D, Avellini C, Bianchi S, Biserni R, Cipriani F, Cocco P, Giacosa A, Marubini E, Puntoni R, Vinigni C, Fraumeni J, Blot W. A case control study of gastric cancer and diet in Italy. Int J Cancer. 1989;44:611\u2013616.", "ArticleIdList": ["2793233"]}, {"Citation": "Cavallito C J, Bailey J H. Allicin, the antibacterial principle of Allium sativum. I. Isolation, physical properties and antibacterial action. J Am Chem Soc. 1944;66:1950\u20131954."}, {"Citation": "Cellini L, Di Campli E, Masulli M, Di Bartolomeo S, Allocati N. Inhibition of Helicobacter pylori by garlic extract (Allium sativum) FEMS Immunol Med Microbiol. 1996;13:273\u2013277.", "ArticleIdList": ["8739190"]}, {"Citation": "Chung J G, Chen G W, Wu L T, Chang H L, Lin J G, Yeh C C, Wang T F. Effects of garlic compounds diallyl sulphide and diallyl disulphide on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients. Am J Chin Med. 1998;26:353\u2013364.", "ArticleIdList": ["9862023"]}, {"Citation": "Dixon M F. Helicobacter pylori and chronic gastritis. In: Rathbone B J, Heatley R V, editors. Helicobacter pylori and gastroduodenal disease. Oxford, United Kingdom: Blackwell Scientific Publications; 1992. pp. 124\u2013139."}, {"Citation": "Feldman R A, Eccersley A J, Hardie J M. Epidemiology of Helicobacter pylori: acquisition, population prevalence and disease-to-infection ratio. Br Med Bull. 1998;54:39\u201353.", "ArticleIdList": ["9604429"]}, {"Citation": "Fortunatov M N. On the activity of the phytoncides from garlic in the human organism upon peroral administration. Farmakol Toksikol. 1955;18:43\u201346.", "ArticleIdList": ["13262120"]}, {"Citation": "Jonkers D, VandenBroek E, VanDooren I, Thijs C, Dorant E, Hageman G, Stobberingh E. Antibacterial effect of garlic and omeprazole on Helicobacter pylori. J Antimicrob Chemother. 1999;43:837\u2013839.", "ArticleIdList": ["10404325"]}, {"Citation": "Koch H P. Biopharmaceutics of garlic's effective compounds. In: Koch H P, Lawson L D, editors. Garlic. The science and therapeutic application of Allium sativum L. and related species. Baltimore, Md: Williams & Wilkins; 1996. pp. 213\u2013220."}, {"Citation": "Koch H P. Toxicity, side effects, and unwanted effects of garlic. In: Koch H P, Lawson L D, editors. Garlic. The science and therapeutic application of Allium sativum L. and related species. Baltimore, Md: Williams & Wilkins; 1996. pp. 221\u2013229."}, {"Citation": "Labez J, Br\u00f6sch G. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol. 1994;89:1785\u20131788.", "ArticleIdList": ["7942667"]}, {"Citation": "Lawson L D. Garlic: a review of its medicinal effects and indicated active compounds. In: Lawson L D, Bauer R, editors. Phytomedicines of Europe: their chemistry and biological activity. ACS Symposium Series 691. Washington, D.C.: American Chemical Society; 1998. pp. 176\u2013209."}, {"Citation": "Lawson L D. The composition and chemistry of garlic cloves and processed garlic. In: Koch H P, Lawson L D, editors. Garlic. The science and therapeutic application of Allium sativum L. and related species. Baltimore, Md: Williams & Wilkins; 1996. pp. 37\u2013107."}, {"Citation": "Lawson L D, Hughes B G. Characterization of the formation of allicin and other thiosulfinates from garlic. Planta Med. 1992;58:345\u2013350.", "ArticleIdList": ["17226483"]}, {"Citation": "Lawson L D, Wang Z Y J, Hughes B G. Identification and HPLC quantification of the sulfides and dialk(en)yl thiosulfinates in commercial garlic products. Planta Med. 1991;57:363\u2013370.", "ArticleIdList": ["1775579"]}, {"Citation": "Lawson L D, Wood S G, Hughes B G. HPLC analysis of allicin and other thiosulfinates in garlic clove homogenates. Planta Med. 1991;57:263\u2013270.", "ArticleIdList": ["17226157"]}, {"Citation": "M\u00e9graud F, Doermann H P. Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. Gut. 1998;43(Suppl.):S61\u2013S65.", "ArticleIdList": ["PMC1766605", "9764043"]}, {"Citation": "Nomura A, Stemmerann G N, Po-Huang C, P\u00e9r\u00e9z-P\u00e9r\u00e9z G I, Blaser M J. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med. 1994;120:977\u2013981.", "ArticleIdList": ["7741826"]}, {"Citation": "Ohta R. In vitro inhibition of the growth of Helicobacter pylori by oil-macerated garlic constituents. Antimicrob Agents Chemother. 1999;43:1811\u20131812.", "ArticleIdList": ["PMC89373", "10438335"]}, {"Citation": "Pasteur L. Memoire sur la fermentation appelle lactique. Ann Chim Phys Ser. 1858;52:404\u2013418."}, {"Citation": "Peitz U, Menegatti M, Vaira D, Malfertheiner P. The European meeting on Helicobacter pylori: therapeutic news from Lisbon. Gut. 1998;43(Suppl):S66\u2013S69.", "ArticleIdList": ["PMC1766600", "9764044"]}, {"Citation": "Pisani P, Parkin D M, Munoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomark Prev. 1997;6:387\u2013400.", "ArticleIdList": ["9184771"]}, {"Citation": "Reuter H D, Koch H P, Lawson L D. Therapeutic effects and applications of garlic and its preparations. In: Koch H P, Lawson L D, editors. Garlic. The science and therapeutic application of Allium sativum L. and related species. Baltimore: Williams & Wilkins; 1996. pp. 135\u2013212."}, {"Citation": "Sivam G P, Lampe J E, Ulness B, Swanzy S R, Potter J D. Helicobacter pylori\u2014in vitro susceptibility to garlic (Allium sativum) extract. Nutr Cancer. 1997;27:118\u2013121.", "ArticleIdList": ["9121937"]}, {"Citation": "Stoll A, Seebeck E. Chemical investigations of alliin, the specific principle of garlic. Adv Enzymol. 1951;11:377\u2013400.", "ArticleIdList": ["24540596"]}, {"Citation": "Warren J R, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;i:1273\u20131275.", "ArticleIdList": ["6134060"]}, {"Citation": "Yoshida H, Iwata N, Katsuzaki H, Naganawa R, Ishikawa K, Fukuda H, Fujino T, Suzuki A. Antimicrobial activity of a compound isolated from an oil-macerated garlic extract. Biosci Biotechnol Biochem. 1998;62:1014\u20131017.", "ArticleIdList": ["9648236"]}, {"Citation": "You W C, Blot W J, Chang Y S, Ershow A G, Yang Z T, An Q, Henderson B, Xu G W, Fraumeni J F, Wang T G. Diet and high risk of stomach cancer in Shandong, China. Cancer Res. 1988;48:3518\u20133523.", "ArticleIdList": ["3370645"]}]}], "History": [{"Year": "2000", "Month": "5", "Day": "2", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "6", "Day": "24", "Hour": "11", "Minute": "0"}, {"Year": "2000", "Month": "5", "Day": "2", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "5", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10788416", "PMC101489", "10.1128/AEM.66.5.2269-2273.2000"]}}], "PubmedBookArticle": []}